Pharmaceutical Medicine - 5511
Program Summary
Faculty: Faculty of Medicine
Contact: drugdev@unsw.edu.au
Campus: Kensington Campus
Career: Postgraduate
Typical Duration: 2 Years
Typical UOC Per Semester: 12
Min UOC Per Semester: 3
Max UOC Per Semester: 12
Min UOC For Award: 48
Award(s):
Graduate Diploma in Pharmaceutical Medicine (Specialisation)
Information valid for students commencing 2013.
Students who commenced prior to 2013 should go to the Handbook's Previous Editions
Program Description
The Graduate Diploma in Pharmaceutical Medicine is a full-fee-paying, part-time, coursework-only programme designed for physicians working in the medical departments of pharmaceutical companies. The programme is compliant with the syllabus required for accreditation as a Pharmaceutical Physician by the International Federation of Associations of Pharmaceutical Physicians (IFAPP). Pharmaceutical physicians are responsible for the conduct of clinical trials, registration of new drugs and associated regulatory activities, pharmacoeconomic studies, supply of drug-related information, pharmacovigilance studies (e.g. monitoring and reporting of adverse drug reactions), and other similar activities. Physicians wishing to advance within the pharmaceutical industry need to develop high levels of skill in the areas mentioned above. This is important for local and international activities and for career development.
Entrance to the Diploma is restricted to qualified medical practitioners having degrees requisite for registration as a medical practitioner in Australia or other jurisdictions considered of comparable standard by the Higher Degree Committee of the Faculty of Medicine.
The Diploma consists of eight core courses, all of which have six Units of Credit (UOC) each.
[One UOC = approximately 25-30 hours of work in total.] Courses are delivered mainly by distance education with one on-campus weekend workshop per course. The teaching year consists of two Sessions (semesters) each of 14 weeks.
This program is suitable for people in full-time employment and is taken on a part-time basis.
The award of the Graduate Diploma in Pharmaceutical Medicine requires the successful completion of the following eight courses. There are no electives in this programme.
Entrance to the Diploma is restricted to qualified medical practitioners having degrees requisite for registration as a medical practitioner in Australia or other jurisdictions considered of comparable standard by the Higher Degree Committee of the Faculty of Medicine.
The Diploma consists of eight core courses, all of which have six Units of Credit (UOC) each.
[One UOC = approximately 25-30 hours of work in total.] Courses are delivered mainly by distance education with one on-campus weekend workshop per course. The teaching year consists of two Sessions (semesters) each of 14 weeks.
This program is suitable for people in full-time employment and is taken on a part-time basis.
The award of the Graduate Diploma in Pharmaceutical Medicine requires the successful completion of the following eight courses. There are no electives in this programme.
Program Objectives and Graduate Attributes
The Postgraduate Diploma in Pharmaceutical Medicine offered by UNSW is based on the syllabus published by the International Federation of Associations of Pharmaceutical Physicians (IFAPP). The objective of the programme is to provide registered medical practitioners who work or hope to work in the pharmaceutical industry with the core competencies needed to practice as pharmaceutical physicians.
Pharmaceutical Physician is the recognized name for medically-qualified people working in the medical departments of pharmaceutical companies. Pharmaceutical physicians are responsible for the conduct of clinical trials, registration of new drugs and associated regulatory activities, pharmacoeconomic studies, supply of drug-related information, pharmacovigilance studies (e.g. monitoring and reporting of adverse drug reactions), and other similar activities.
Need for a Program
For Australia to play its full role in drug development, particularly early-phase drug development, and to maintain high standards of drug delivery, it is essential that Australian pharmaceutical physicians are adequately skilled in the areas mentioned above and that these skills meet assessable standards and are compatible with international scientific, legal, regulatory and semantic conventions. This is important for local and international activities and for career development.
Learning Outcomes
Assessment will be based on the ability to apply principles to problem solving. There will be minimal emphasis on memorization of factual material. Both written exams and assignments will be based on scenarios i.e. case-type situations that require the exercise of comprehension, judgement and an understanding of the issues involved.
Education and Assessment
Will be based on high-quality information delivery, application of this information through assignment work, and written examinations. This will form the platform for the assignment work that will be based mainly on the primary (i.e. research) literature. A key feature of assignment work will be development of critical appraisal skills for research papers. Students will also be issued with workbooks for each course that will set out assignment work and other tasks. This will be supported by the on-line learning system, Blackboard, which provides all course information including assignment work, student questions and answers, chat rooms, etc. Students will study the manuals at their own pace within allocated time periods (nine weeks per course). There will be telephone tutorials for each course and two weekend workshops per Session. Tutors will be available for Q&A by email.
Pharmaceutical Physician is the recognized name for medically-qualified people working in the medical departments of pharmaceutical companies. Pharmaceutical physicians are responsible for the conduct of clinical trials, registration of new drugs and associated regulatory activities, pharmacoeconomic studies, supply of drug-related information, pharmacovigilance studies (e.g. monitoring and reporting of adverse drug reactions), and other similar activities.
Need for a Program
For Australia to play its full role in drug development, particularly early-phase drug development, and to maintain high standards of drug delivery, it is essential that Australian pharmaceutical physicians are adequately skilled in the areas mentioned above and that these skills meet assessable standards and are compatible with international scientific, legal, regulatory and semantic conventions. This is important for local and international activities and for career development.
Learning Outcomes
Assessment will be based on the ability to apply principles to problem solving. There will be minimal emphasis on memorization of factual material. Both written exams and assignments will be based on scenarios i.e. case-type situations that require the exercise of comprehension, judgement and an understanding of the issues involved.
Education and Assessment
Will be based on high-quality information delivery, application of this information through assignment work, and written examinations. This will form the platform for the assignment work that will be based mainly on the primary (i.e. research) literature. A key feature of assignment work will be development of critical appraisal skills for research papers. Students will also be issued with workbooks for each course that will set out assignment work and other tasks. This will be supported by the on-line learning system, Blackboard, which provides all course information including assignment work, student questions and answers, chat rooms, etc. Students will study the manuals at their own pace within allocated time periods (nine weeks per course). There will be telephone tutorials for each course and two weekend workshops per Session. Tutors will be available for Q&A by email.
Program Structure
The Postgraduate Diploma in Pharmaceutical Medicine is provided only as a part-time mainly distance delivered coursework only programme.
Teaching Arrangements. The teaching year will consist of two 14-week Sessions. Students will take two courses each Session Written examinations will be held at the end of each Session and assignments relevant to the topic must be handed in before the end of examination day. The programme will be part time and mainly distance delivered with the only on-campus component being the weekend workshop.
Mentor System
Each student will be allocated a mentor within the medical department of a pharmaceutical company. In most cases, students will be new recruits and the mentor will be the medical director of the company for which the student works. Otherwise, the mentor will be chosen from a pharmaceutical company that is a member of Medicines Australia (the industry association of the Australian pharmaceutical industry). Students will be required to spend a minimum specified time (12-18 hours) with the mentor’s medical department. During this time, students will perform specified tasks and submit reports on these tasks to their mentor. The mentor will report to the Programme Coordinator on the student’s progress.
Teaching Arrangements. The teaching year will consist of two 14-week Sessions. Students will take two courses each Session Written examinations will be held at the end of each Session and assignments relevant to the topic must be handed in before the end of examination day. The programme will be part time and mainly distance delivered with the only on-campus component being the weekend workshop.
Mentor System
Each student will be allocated a mentor within the medical department of a pharmaceutical company. In most cases, students will be new recruits and the mentor will be the medical director of the company for which the student works. Otherwise, the mentor will be chosen from a pharmaceutical company that is a member of Medicines Australia (the industry association of the Australian pharmaceutical industry). Students will be required to spend a minimum specified time (12-18 hours) with the mentor’s medical department. During this time, students will perform specified tasks and submit reports on these tasks to their mentor. The mentor will report to the Programme Coordinator on the student’s progress.
Year 1
Session 1
Session 2
Year 2
Session 1
Session 1
Session 2
- PHAR9103 Biostatistics and Trial Design (6 UOC)
- PHAR9124 Economic Drivers (6 UOC)
Academic Rules
- Award of the Graduate Diploma may be made to a candidate who has satisfactorily completed the approved programme of study.
- Qualifications: A candidate for the diploma shall be a qualified medical practitioner, having been awarded degrees requisite for registration as a medical practitioner in Australia or other jurisdictions considered of comparable standard by the Higher Degree Committee of the Faculty of Medicine (hereinafter referred to as the Committee).
- Enrolment and progression:
- a) An application to enrol as a candidate for the diploma shall be made on the prescribed form which shall be lodged with the Registrar by the advertised closing date, which shall be at least two months before the commencement of the session in which enrolment is to begin.
- b) A candidate for the diploma shall be required to undertake the subjects, and pass any assessment, prescribed.
- c) The progress of a candidate shall be reviewed by the end of two sessions by the Committee and as a result of its review the Committee may cancel enrolment or take such other action as it considers appropriate.
- d) The programme will be offered only on a part-time basis. The normal duration is four academic sessions from the date of enrolment. In special circumstances a variation of these times may be approved by the Head of School.
- Fees:A candidate shall pay such fees as may be determined from time to time by the Council.
Fees
For information regarding fees for UNSW programs, please refer to the following website: https://my.unsw.edu.au/student/fees/FeesMainPage.html
Area(s) of Specialisation
Study Levels
UNSW Quick Links
